Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 301–315 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3646 TMEM67 Gene (Meckel Syndrome Type 3) Genetic Test This genetic test identifies pathogenic variants in the TMEM67 gene associated with Meckel syndrome type 3.	Whole Blood (EDTA), Extracted DNA, or FTA Card Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TMEM67 gene"] Parameters [] Preparation ["No fasting required", "Avoid strenuous exercise 2 hours prior to draw"] Indications ["Suspected Meckel syndrome type 3", "Carrier screening in families with a history of MKS3", "Prenatal diagnosis", "Informed reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 81316-6 ICD-10: Q61.9 Clinical summary This genetic test identifies pathogenic variants in the TMEM67 gene associated with Meckel syndrome type 3.
TEST-5954 TNFRSF1A Gene Periodic Fever (TRAPS) Genetic Test This genetic test identifies pathogenic variants in the TNFRSF1A gene, which are the cause of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS).	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNFRSF1A gene", "Copy Number Variations (CNV) in the TNFRSF1A gene"] Parameters [] Preparation [] Indications ["Clinical suspicion of TRAPS based on symptoms and family history", "Guiding therapy with IL-1 inhibitors", "Screening at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 83504-5 ICD-10: M04.1 Clinical summary This genetic test identifies pathogenic variants in the TNFRSF1A gene, which are the cause of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS).
TEST-4278 TNNI3 Gene Familial Hypertrophic Cardiomyopathy Type 7 DNA Test This test identifies pathogenic variants in the TNNI3 gene associated with familial hypertrophic cardiomyopathy type 7.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNI3 gene", "Single nucleotide variants", "Small insertions/deletions", "Splice-site mutations"] Parameters [] Preparation ["Detailed clinical history required", "Mandatory pre-test genetic counselling session", "Construction of a three-generation pedigree"] Indications ["Diagnosis of familial hypertrophic cardiomyopathy type 7", "Family screening for FHC7", "Risk assessment in individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 93929-2 ICD-10: I42.1 Clinical summary This test identifies pathogenic variants in the TNNI3 gene associated with familial hypertrophic cardiomyopathy type 7.
TEST-5298 TNNT1 Gene Nemaline Myopathy Type 5 Genetic Test This test identifies pathogenic variants in the TNNT1 gene associated with nemaline myopathy type 5.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TNNT1 gene", "Coding region and splice site variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any bleeding disorders"] Indications ["Suspected nemaline myopathy type 5", "Congenital muscle disorder diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: G71.2 Clinical summary This test identifies pathogenic variants in the TNNT1 gene associated with nemaline myopathy type 5.
TEST-3125 TP63 Gene ADULT Syndrome & Split Hand-Foot Malformation Genetic Test This test evaluates the TP63 gene for pathogenic variants associated with ADULT syndrome and split hand-foot malformation.	Peripheral Whole Blood or DBS on FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation [] Indications ["Diagnosis of ADULT syndrome", "Diagnosis of split hand-foot malformation", "Family planning for individuals with ADULT syndrome or split hand-foot malformation", "Evaluation of individuals with characteristic clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 94218-3 ICD-10: Q71.6, Q87.2 Clinical summary This test evaluates the TP63 gene for pathogenic variants associated with ADULT syndrome and split hand-foot malformation.
TEST-2410 TP63 Gene Rapp-Hodgkin Syndrome Genetic Test This genetic test analyzes the TP63 gene to identify mutations causing Rapp-Hodgkin syndrome.	Whole Blood (EDTA) or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TP63 gene", "Missense, nonsense, and splice-site variants"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any relevant medications"] Indications ["Clinical suspicion of ectodermal dysplasia", "Family history of Rapp-Hodgkin syndrome", "Genetic counseling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q82.4 Clinical summary This genetic test analyzes the TP63 gene to identify mutations causing Rapp-Hodgkin syndrome.
TEST-3916 TRIM32 Gene (Bardet-Biedl Syndrome Type 11) NGS Test This test detects pathogenic variants in the TRIM32 gene associated with Bardet-Biedl syndrome type 11.	Whole Blood or FTA Card	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRIM32 gene"] Parameters [] Preparation ["No fasting or special preparation is required"] Indications ["Individuals with clinical features suggestive of Bardet-Biedl syndrome type 11", "Family members of affected individuals seeking carrier or predictive testing"] Measurement technique Confirm with laboratory Codes LOINC: 50397-9 ICD-10: Q87.8 Clinical summary This test detects pathogenic variants in the TRIM32 gene associated with Bardet-Biedl syndrome type 11.
TEST-4523 TRPS1 Gene (Trichorhinophalangeal Syndrome Type 1) Genetic Test This test identifies pathogenic variants in the TRPS1 gene associated with Trichorhinophalangeal Syndrome Type 1.	Whole Blood (3–5 mL) or Dried Blood Spot (FTA Card)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPS1 gene", "Full coding exons and splice sites"] Parameters [] Preparation ["No fasting required"] Indications ["Clinical suspicion of Trichorhinophalangeal Syndrome Type 1 (TRPS I)", "Family history of TRPS I"] Measurement technique Confirm with laboratory Codes LOINC: 94218-9 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the TRPS1 gene associated with Trichorhinophalangeal Syndrome Type 1.
TEST-2665 TRPS1 Gene Langer‑Giedion Syndrome Genetic Test This test detects pathogenic variants in the TRPS1 gene to confirm a diagnosis of Langer‑Giedion syndrome.	Peripheral Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TRPS1 gene", "Point mutations", "Small insertions/deletions", "Copy number variations"] Parameters [] Preparation ["Genetic counselling session required", "Signed informed consent required"] Indications ["Clinical suspicion of Langer‑Giedion syndrome", "Family history of Langer‑Giedion syndrome", "Carrier testing", "Family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q87.1 Clinical summary This test detects pathogenic variants in the TRPS1 gene to confirm a diagnosis of Langer‑Giedion syndrome.
TEST-5507 TSEN54 Gene Pontocerebellar Hypoplasia Type 5 Genetic Test This genetic test identifies pathogenic variants in the TSEN54 gene associated with pontocerebellar hypoplasia type 5.	Peripheral whole blood or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TSEN54 gene"] Parameters [] Preparation [] Indications ["Diagnosis of pontocerebellar hypoplasia type 5", "Family planning for PCH5"] Measurement technique Confirm with laboratory Codes LOINC: 54236-8 ICD-10: Q04.8 Clinical summary This genetic test identifies pathogenic variants in the TSEN54 gene associated with pontocerebellar hypoplasia type 5.
TEST-3622 TSPAN12 Gene Exudative Vitreoretinopathy Type 5 Genetic Test This test identifies pathogenic variants in the TSPAN12 gene associated with familial exudative vitreoretinopathy type 5.	Peripheral Whole Blood (EDTA) or FTA Card (Dried Blood Spot)	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TSPAN12 gene sequence", "TSPAN12 gene copy number variants"] Parameters [] Preparation [] Indications ["Diagnosis of familial exudative vitreoretinopathy type 5", "Carrier screening in families with known TSPAN12 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 21613-5 ICD-10: H35.0 Clinical summary This test identifies pathogenic variants in the TSPAN12 gene associated with familial exudative vitreoretinopathy type 5.
TEST-5165 TTC19 Gene Mitochondrial Complex III Deficiency, Nuclear Type 2 Genetic Test This genetic test identifies pathogenic mutations within the TTC19 gene, which are responsible for causing mitochondrial complex III deficiency, a condition affecting neurological...	Whole Blood (2–3 mL EDTA), Extracted DNA (1 µg), or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the TTC19 gene", "Mitochondrial complex III deficiency"] Parameters [] Preparation ["Provide detailed clinical history", "Mandatory genetic counselling session", "Avoid CoQ10 or idebenone for 48 hours prior"] Indications ["Confirmation of suspected mitochondrial complex III deficiency", "Carrier screening in families with affected members", "Genetic counseling for reproductive planning"] Measurement technique Confirm with laboratory Codes LOINC: 83573-1 ICD-10: E88.49 Clinical summary This genetic test identifies pathogenic mutations within the TTC19 gene, which are responsible for causing mitochondrial complex III deficiency, a condition affecting neurological function.
TEST-4566 TTN Gene Hereditary Myopathy with Early Respiratory Failure Genetic Test This genetic test evaluates the TTN gene for pathogenic variants associated with hereditary myopathy with early respiratory failure (HMERF).	Peripheral whole blood (EDTA, 3–5 mL); alternative: extracted DNA (≥1 µg) or dried blood spot on FTA card. FFPE tissue blocks accepted on a case-by-case basis.	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TTN gene", "Exon-level Copy Number Variations (CNV)"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "No specific fasting or medication adjustments required unless advised by physician"] Indications ["Diagnosis of HMERF", "Genetic counselling for families with HMERF", "Carrier screening in individuals with family history"] Measurement technique Confirm with laboratory Codes LOINC: 21678-5 ICD-10: G71.0 Clinical summary This genetic test evaluates the TTN gene for pathogenic variants associated with hereditary myopathy with early respiratory failure (HMERF).
TEST-2634 TUBA1A Gene Lissencephaly Type 3 Genetic Test This test evaluates the TUBA1A gene for pathogenic variants associated with lissencephaly type 3.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the TUBA1A gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Ensure child is well-hydrated", "No fasting required", "Topical anaesthetic cream may be applied 30 minutes before collection"] Indications ["Suspected diagnosis of lissencephaly type 3", "Family history of lissencephaly", "Genetic counselling for families with affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 101673-8 ICD-10: Q04.3, Q02, Z13.71 Clinical summary This test evaluates the TUBA1A gene for pathogenic variants associated with lissencephaly type 3.
TEST-4493 TUFT1 Gene Tuftelin Deficiency Genetic Test This test evaluates the TUFT1 gene for mutations associated with tuftelin deficiency, which can cause enamel defects and immune system issues.	Peripheral whole blood (3–5 mL in EDTA tube) or saliva (Oragene kit)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["TUFT1 gene sequence", "Pathogenic variants in TUFT1"] Parameters [] Preparation [] Indications ["Amelogenesis imperfecta", "Enamel hypoplasia", "Immune-mediated syndromes", "Dermatological fragility"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: K00.5 Clinical summary This test evaluates the TUFT1 gene for mutations associated with tuftelin deficiency, which can cause enamel defects and immune system issues.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.